cardiovascular system-凯发k8娱乐app下载

cardiovascular system-凯发k8娱乐app下载

  • wanbang biopharmaceuticals

    heparin sodium injection

    common name:heparin sodium injection

    to prevent the formation of deep vein thrombosis and embolistic diseases, etc.

  • wanbang biopharmaceuticals

    bang zhi

    common name:pitavastatin calcium tablets

    hypercholesterolemia, familial hypercholesterolemia.

  • wanbang biopharmaceuticals

    bang tan

    common name:telmisartan tablets

    for the treatment of hypertension. reduce cardiovascular risk.

  • shanghai zhaohui pharmaceutical co., ltd.

    ke yuan

    common name:calcium dobesilate capsules

    for diabetic retinopathy

  • wanbang biopharmaceuticals

    xin xian an

    common name:meglumine adenosine cyclophosphate injection

    to treat coronary heart disease, cardiac failure, cardiac arrhythmia and sick sinus syndrome

  • yaopharma co., ltd.

    you di er

    common name:alprostadil dried emulsion for injection

    it is a national key new product and its core technology won the second prize of national science and technology progress award. it is a targeted vasodilator that can effectively improve microcirculation disorders. it is indicated for improvement of cardiovascular and cerebrovascular microcirculation disorders, anti-thrombotic treatment after organ transplantation, hypoxemia relief in treatment of ductus dependent congenital heart diseases, and auxiliary treatment of chronic hepatitis.

  • yaopharma co., ltd.

    ya ni an/shi li da®

    common name:amlodipine besilate tablets

    listed in the national essential medicines list, national reimbursement drug list (category a) and national centralized drug procurement list the third-generation calcium ion antagonists and the first-line antihypertensive drug recommended by authoritative chinese and international guidelines.

  • yaopharma co., ltd.

    芬卡欣®

    common name:indapamide tablets

    listed in the national essential medicines list, national reimbursement drug list (category a) and national centralized drug procurement list first-line antihypertensive drug recommended by authoritative chinese and international guidelines. with dual effects of diuresis and vasodilation.